Viewing Study NCT00144768


Ignite Creation Date: 2025-12-24 @ 5:29 PM
Ignite Modification Date: 2025-12-25 @ 3:03 PM
Study NCT ID: NCT00144768
Status: COMPLETED
Last Update Posted: 2014-05-05
First Post: 2005-09-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients
Sponsor: Genzyme, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module